Moshe Ben-Shoshan Selected Research

Epinephrine (Adrenaline)

2/2022	Food Allergy Education and Management in Schools: A Scoping Review on Current Practices and Gaps.
1/2022	Sesame-induced anaphylaxis in pediatric patients from the cross-Canada anaphylaxis registry.
1/2022	Prevalence, Management, and Anaphylaxis Risk of Cold Urticaria: A Systematic Review and Meta-Analysis.
1/2022	Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management.
1/2022	Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: Rates, clinical presentation, and management.
1/2021	Fruit-Induced Anaphylaxis: Clinical Presentation and Management.
1/2021	Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis.
9/2019	Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort.
1/2019	Emergency Management of Anaphylaxis Due to an Unknown Trigger: An 8-Year Follow-Up Study in Canada.
1/2019	Teenagers and those with severe reactions are more likely to use their epinephrine autoinjector in cases of anaphylaxis in Canada.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moshe Ben-Shoshan Research Topics

Disease

37	Hypersensitivity (Allergy) 01/2022 - 11/2008
36	Anaphylaxis (Anaphylactic Shock) 02/2022 - 11/2008
10	Food Hypersensitivity (Food Allergy) 01/2022 - 08/2011
9	Asthma (Bronchial Asthma) 01/2022 - 11/2008
7	Chronic Urticaria 01/2022 - 03/2020
6	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 06/2008
6	Urticaria (Hives) 01/2021 - 11/2008
4	Atopic Dermatitis (Atopic Eczema) 01/2022 - 11/2008
4	Milk Hypersensitivity (Milk Allergy) 01/2020 - 11/2012
3	Angioedema 01/2022 - 11/2008
3	Hypoxia (Hypoxemia) 01/2022 - 04/2007
3	Exanthema (Rash) 01/2021 - 07/2009
3	Hypotension (Low Blood Pressure) 07/2019 - 05/2013
3	Infections 01/2019 - 01/2012
2	Bullous Pemphigoid (Pemphigoid) 07/2022 - 01/2022
2	Chronic Inducible Urticaria 01/2022 - 10/2021
2	Drug Hypersensitivity (Drug Allergy) 01/2022 - 06/2017
2	Inflammation (Inflammations) 01/2022 - 05/2018
2	Neoplasms (Cancer) 08/2012 - 04/2007
1	Bacterial Infections (Bacterial Infection) 03/2022
1	WHIM syndrome 03/2022
1	Lymphopenia (Lymphocytopenia) 03/2022
1	Neutropenia 03/2022
1	Cyanosis 01/2022
1	Shellfish Hypersensitivity 01/2022
1	Cold Urticaria 01/2022
1	Dermatitis 01/2022
1	Eosinophilia 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Shock 01/2022
1	COVID-19 01/2022
1	Respiratory Sounds (Crackle) 01/2022
1	Insect Bites and Stings (Insect Bite) 01/2022
1	Mastocytosis 01/2022
1	Neurodermatitis (Lichen Simplex Chronicus) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Arthritis (Polyarthritis) 01/2021
1	Serum Sickness 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Proctocolitis (Hemorrhagic Proctocolitis) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Colitis 05/2018
1	Weight Loss (Weight Reduction) 05/2018

Drug/Important Bio-Agent (IBA)

23	Epinephrine (Adrenaline)FDA LinkGeneric 02/2022 - 06/2008
12	Immunoglobulin E (IgE)IBA 01/2022 - 11/2008
10	AllergensIBA 01/2022 - 01/2013
9	Omalizumab (Xolair)FDA Link 07/2022 - 11/2008
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2016
8	Penicillins (Penicillin)FDA Link 11/2021 - 08/2016
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2007
5	Pharmaceutical PreparationsIBA 01/2021 - 06/2009
5	LactamsIBA 01/2021 - 08/2016
4	Histamine Antagonists (Antihistamines)IBA 01/2022 - 11/2017
4	Amoxicillin (Wymox)FDA LinkGeneric 11/2021 - 01/2016
4	beta-LactamsIBA 01/2021 - 01/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
3	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	Monoclonal AntibodiesIBA 01/2022 - 11/2010
2	CytokinesIBA 01/2022 - 05/2018
2	VaccinesIBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	Polysorbates (PSML)FDA Link 01/2022 - 10/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2013
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 10/2021
2	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 11/2020 - 06/2020
2	Tryptases (Tryptase)IBA 01/2020 - 04/2016
2	Ibuprofen (Motrin)FDA LinkGeneric 01/2020 - 01/2013
2	VenomsIBA 01/2018 - 12/2015
2	Filaggrin ProteinsIBA 07/2013 - 03/2011
2	Vitamin D FDA LinkGeneric 08/2012 - 04/2007
1	Immunoglobulin A (IgA)IBA 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	Immunoglobulins (Immunoglobulin)IBA 03/2022
1	dupilumabIBA 01/2022
1	BradykininIBA 01/2022
1	Contrast MediaIBA 01/2022
1	LatexIBA 01/2022
1	Excipients (Suspending Agents)IBA 10/2021
1	Cytidine Monophosphate (CMP)IBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 09/2020
1	ligelizumabIBA 03/2020
1	Pea ProteinsIBA 07/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Cefazolin (Ancef)FDA LinkGeneric 01/2019
1	MacrolidesIBA 01/2019
1	SulfonamidesIBA 01/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019
1	16S Ribosomal RNAIBA 05/2018
1	Dextrans (Dextran)FDA Link 05/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2018
1	InterleukinsIBA 05/2018
1	interleukin-21 (interleukin 21)IBA 01/2018
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2018

Therapy/Procedure

8	Immunotherapy 01/2021 - 11/2012
4	Therapeutics 01/2022 - 04/2007
1	Antibiotic Prophylaxis 05/2018